Drugs / CTX
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT05814731 Background | Apr 2023 → Dec 2025 | disease related to hematopoietic stem cell transplant | First Affiliated Hospital Xi'an Jiaotong University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CTX | “CTX 1.8 g/m2.d ，ivgtt，d-5- -4” NCT05814731 ↗ |
| Route | Intravenous | “CTX 1.8 g/m2.d ，ivgtt，d-5- -4” NCT05814731 ↗ |